News

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...
The review extension was needed as the FDA required time to review Cytokinetics’ proposed Risk Evaluation and Mitigation Strategy (REMS).
The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.
Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients.
Environmental Health Perspectives, a journal funded by the National Institutes of Health (NIH), announced that it would pause new submissions.
Urcosimod is a lipid conjugated ChemR23 chemerin peptide agonist that is designed to reduce inflammation and pain in the eye.
Florida state lawmakers have approved a bill to ban the addition of fluoride to public drinking water, a move that public health experts say could harm dental health across the state.
The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...
Polycystic ovarian syndrome (PCOS) is a complex disorder of metabolism, endocrine function, and the reproductive system that affects an estimated 1 in 10 ...
Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy.
The FDA is expected to decide on treatments for bullous pemphigoid, hereditary angioedema, HIV PrEP, ovarian cancer, and RSV.